A Peptide Derived from Nectin-4 Increases Cisplatin Cytotoxicity in Cell Lines and Cells from Ovarian Cancer Patients' Ascites. [PDF]
Boylan KLM +3 more
europepmc +1 more source
A novel and promising therapeutic approach for treating pancreatic cancer: Nectin‑4‑targeted antibody‑drug conjugates alone or combined with autophagy inhibitors. [PDF]
Fu R +8 more
europepmc +1 more source
Rapid and specific immunoPET imaging of Nectin-4 in gastric cancer and non-small cell lung cancer using [64Cu]Cu-NOTA-EV-F(ab')2. [PDF]
Huang W +11 more
europepmc +1 more source
Exploring membranous NECTIN-4 expression patterns and enfortumab vedotin response in prostate cancer. [PDF]
Weiten R +10 more
europepmc +1 more source
PD-L1 and nectin-4 expression and genomic characterization of bladder cancer with divergent differentiation. [PDF]
Martini DJ +16 more
europepmc +1 more source
Exploring novel therapeutic targets in small bowel adenocarcinoma: insights from claudin 18.2, nectin-4, and HER3 expression analysis. [PDF]
Fujii H +6 more
europepmc +1 more source
Near-infrared photoimmunotherapy targeting Nectin-4 in a preclinical model of bladder cancer. [PDF]
Fukushima H +9 more
europepmc +1 more source
TROP-2, NECTIN-4 and predictive biomarkers in sarcomatoid and rhabdoid bladder urothelial carcinoma. [PDF]
Brunelli M +20 more
europepmc +1 more source
Successful treatment with enfortumab-vedotin of metastatic signet ring cell cancer expressing nectin-4 and originating from the bladder. [PDF]
Aoki M +9 more
europepmc +1 more source

